Latanoprost Viatris

Latanoprost, the active ingredient in Latanoprost Viatris, is a prostaglandin analog presented as an ophthalmic solution for ocular use. It lowers intra‑ocular pressure and is indicated for open‑angle glaucoma and ocular hypertension in adult patients. GNH USA supplies Latanoprost Viatris as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost is a prostaglandin analog that increases outflow of aqueous humor to manage elevated eye pressure. - Open-angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: lowers pressure to prevent progression to glaucoma. - Elevated intra‑ocular pressure: helps maintain normal pressure levels and protect visual function.

Latanoprost may cause ocular and systemic reactions.

Common Side Effects: - Eye redness: mild conjunctival hyperemia. - Eye itching: transient pruritus. - Blurred vision: temporary visual disturbance after instillation. - Increased eyelash growth: longer, thicker lashes.

Serious or Rare Side Effects: - Severe eye inflammation: uveitis or iritis requiring medical attention. - Allergic reaction: swelling, rash, or systemic hypersensitivity. - Vision loss: sudden decrease in visual acuity.

Before using Latanoprost, consider the following safety measures. - Monitor intra‑ocular pressure: schedule regular measurements after starting therapy. - Assess for ocular infection: avoid use if active conjunctivitis or keratitis is present. - Avoid contact lens wear: discontinue lenses during treatment to reduce irritation. - Pregnancy and lactation: safety unknown; prescribe only if benefit outweighs potential risk. - Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Concomitant prostaglandin analogs: additive ocular effects may increase irritation. - Non‑steroidal anti‑inflammatory eye drops: may diminish Latanoprost efficacy.

Moderate Interactions (Monitor Closely): - Beta‑blocker eye drops: monitor intra‑ocular pressure for additive lowering. - Systemic carbonic anhydrase inhibitors: potential enhanced pressure reduction. - Topical corticosteroids: increased risk of ocular side effects.